Vertex Pharmaceuticals Incorporated Earnings

Vertex Pharmaceuticals Incorporated’s revenue jumped 15.66% since last year same period to $2912Mn in the Q4 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 5.05% jump in its revenue since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit fell -5.76% since last year same period to $913Mn in the Q4 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated -12.67% fall in its net profits since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit margin fell -18.52% since last year same period to 31.35% in the Q4 2024. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated -16.87% fall in its net profit margins since last 3-months.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current quarter stand at 4.02 - a -2.89% fall from last quarter’s estimates.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current year stand at 4.02.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) fell -5.24% since last year same period to 3.98 in the Q4 2024. This indicates that the Vertex Pharmaceuticals Incorporated has generated -5.24% annual rate of fall in its earning per share (EPS) in the last 4 quarters.